openPR Logo
Press release

Pharmascroll launches operations in Customized Pharmaceutical Marketing Research

03-07-2018 04:50 PM CET | Health & Medicine

Press release from: Pharmascroll Research and Consulting Private Limited

Pharmascroll launches operations in Customized

Pharmascroll, a Market Research and Consulting firm registered and launched in June 2017, has been a renowned Syndicated research provider in Pharmaceutical space. Pharmascroll has generated over 30 market research reports in multiple disease indications including Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis and Migraine disease indications in less than a year of the launch of company. The reports generated by the company are extensive covering the disease insights, etiology, epidemiology along with forecast, pipeline and current drugs overview including Forecasts for 15 years for a disease indication.

In addition to the Syndicated Research Business, Pharmascroll has now announced entry into the Customized Market Research Business in Pharmaceutical domain. The company plans to offer customized research for the companies and partners based on their requirements and business needs in the following broad areas- Understanding disease overview, Disease epidemiology, Drugs and market overview, Drug pipeline review, Drug Attribute analysis, Market Forecasts, Competitive Intelligence information, Monthly/Quarterly research reports/newsletter updates, understanding physician and customer insights based on publicly available data.

“Pharmascroll has gained success in the Syndicated Research Business in a very short span of time. We have thousands of followers including physicians, patients and pharma company representatives on our social media pages including LinkedIn and twitter. This displays the confidence of our prospective customers in our Research and Analytics abilities. Backed by the strength of success of our Syndicated Research Business, we would now like to offer Customized Market Research services to Pharmaceutical firms including other Pharma Market Research firms to better cater to their needs and help the patients in getting better treatments and information in longer term.” Said, Bhawna Gupta, Director, Pharmascroll.

To know more about the company, visit the website www.pharmascroll.com

Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.

First Office,
Madhapur,
Hi Tech City
Hyderabad, India
Bhawna Gupta
+919776868067

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmascroll launches operations in Customized Pharmaceutical Marketing Research here

News-ID: 967987 • Views: 299

More Releases from Pharmascroll Research and Consulting Private Limited

Pharmascroll offers Social Media Analytics services for Pharmaceutical and Healt …
Pharmascroll, a renowned Market Research and Business Consulting firm, has been offering research services to Healthcare and Pharmaceutical firms since over 3 years. Pharmascroll has published 70+ syndicated reports in multiple disease indications and has served 30+ market research clients in the Pharmaceutical and Healthcare domain. The firm has catered to customers across Global markets including US, Europe and Asian countries. The firm currently offers research services in the areas
Pharmascroll offering Quality Healthcare and Pharmaceutical Market Research serv …
Pharmascroll, a Market Research and Consulting firm, has been a renowned Syndicated and customized research provider across the Healthcare and Pharmaceutical space. Pharmascroll has generated over 75 market research reports in multiple disease indications and has consulted and researched for several Global clients across multiple areas. Global Market Research Industry exceeded 44 Bn USD in revenues in 2015 and around 14% of the market research revenues registered across the Globe
Schizophrenia: Disease Insights & Market Forecasts to 2024 by Pharmascroll
“Schizophrenia: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Schizophrenia disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Schizophrenia, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024. Geographies covered: US Germany France Italy Spain UK Japan Australia Canada Drugs
Epilepsy: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“Epilepsy: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Epilepsy disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Epilepsy, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024. Geographies covered: US Germany France Italy Spain UK Japan Australia Canada Drugs

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business